Skip to content

A New Risk Score for the Emergency Department in Patients with Upper Gastrointestinal Bleeding

Comparison of the New Risk Score (ABL Score) with the Glasgow Blatchford Score, AIMS65, and Pre-Endoscopic Rockall Score in Patients with Upper Gastrointestinal Bleeding Admitted to the Emergency Department

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06878183
Enrollment
589
Registered
2025-03-14
Start date
2022-01-01
Completion date
2023-06-01
Last updated
2025-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency Department Patient, Risk Scores, Upper Gastrointestinal Bleeding (UGIB)

Keywords

Emergency department, Upper gastrointestinal bleeding, AIMS65, pre-RS, Glaskow Blatchfor Score, Risk score

Brief summary

Abstract Background: The aim of this study was to develop a simpler, more practical, and highly effective risk scoring system for patients presenting to the emergency department with upper gastrointestinal bleeding. Methods: This single-center retrospective observational study was conducted by reviewing data from patients aged 18 years and older who presented to the Emergency Medicine Clinic of Sakarya Training and Research Hospital with symptoms and signs of upper gastrointestinal bleeding between January, 2022 to June, 2023. Patients were divided into six groups for analysis. Patients included in the transfusion, intervention, intense care unit, readmission or mortality groups were classified as high risk. Using the obtained data, a new scoring system was developed, and its effectiveness in predicting high risk and all subgroups was compared with the Glasgow Blatchford Score, AIMS65, and pre-endoscopic Rockall Score.

Interventions

OTHERRoutine laboratory tests of the patients were examined (such as hemogram, biochemistry, bleeding parameters).

Data obtained from routine examinations, laboratory tests and hospital reports were evaluated.

Sponsors

Sakarya University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients aged over 18 years who presented to the ED with UGIB symptoms and signs (hematemesis, melena, and hematochezia) and were hospitalized between January 1, 2022, and June 1, 2023, were included in the study.

Exclusion criteria

* Patients with insufficient data, lower gastrointestinal bleeding, or those who did not undergo endoscopy due to death, refusal of treatment, or symptom resolution were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Develop a new risk score capable of predicting the high-risk group1 yearThe primary outcome was to develop a new risk score that can predict the high-risk group in the emergency department in patients with upper gastrointestinal bleeding. In the new risk score, high scores were intended to be more associated with high risk.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026